No-Scar surgery for endometrial cancer? new study tests vNOTES against standard laparoscopy
NCT ID NCT07583329
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two minimally invasive surgical methods for early-stage endometrial cancer: standard laparoscopy (small abdominal cuts) and vNOTES (surgery through the vagina with no visible scars). Researchers will enroll 160 women to see how well each method finds sentinel lymph nodes, which help determine if cancer has spread. The goal is to see if vNOTES is as safe and effective as laparoscopy, with potential benefits like less pain and faster recovery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 160 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2036
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Histologically confirmed endometrial cancer on preoperative endometrial biopsy
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥18 years * Histologically confirmed endometrial cancer on preoperative endometrial biopsy * Disease confirmed to be confined to the uterus based on clinical evaluation and imaging * No evidence of lymphatic or distant metastasis on positron emission tomography/computed tomography(PET/CT) or magnetic resonance imaging (MRI) * Surgical staging with sentinel lymph node biopsy recommended by a multidisciplinary tumor board * Surgical treatment performed using either conventional laparoscopy or the vNOTES approach Exclusion Criteria: * Presence of extrauterine disease * Detection of distant metastasis * Surgery performed via an open (laparotomy) approach * Incomplete medical records * History of prior pelvic radiotherapy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Endometrial adenocarcinoma are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Cukurova Univercity
Adana, 01000, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug shrink tumors that resist standard care?
- Can protein patterns in stored tumors point to new treatment targets?
- Can a pill target cancers with a specific gene flaw?
- Why is endometrial cancer often advanced in brazil? a new study digs into the data
- Can a new pill outsmart mutant cancers?
- Can five radiation doses replace weeks of treatment for endometrial cancer?